Carlisle (NYSE: CSL) CFO exercises options and sells 24,180 shares

Rhea-AI Filing Summary

Carlisle Companies VP & Chief Financial Officer Kevin P. Zdimal reported multiple share transactions in company common stock. On February 10, 2026, he exercised 7,720 employee stock options at an exercise price of $222.35 per share, converting them into common stock.

That same day, he sold a total of 24,180 common shares in a series of market transactions at weighted average prices ranging from about $405.19 to $417.61, each executed in multiple trades within stated price ranges. After these transactions, he beneficially owned 30,094 common shares, all held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zdimal Kevin P

(Last) (First) (Middle)

C/O CARLISLE COMPANIES INCORPORATED

16430 N. SCOTTSDALE ROAD, SUITE 400

(Street)

SCOTTSDALE AZ 85254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CARLISLE COMPANIES INC [ CSL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/10/2026		M		7,720	A	$222.35	54,274	D
Common Stock	02/10/2026		S		2,306	D	$405.19(1)	51,968	D
Common Stock	02/10/2026		S		5,414	D	$406.08(2)	46,554	D
Common Stock	02/10/2026		S		5,824	D	$405.44(3)	40,730	D
Common Stock	02/10/2026		S		4,199	D	$406.26(4)	36,531	D
Common Stock	02/10/2026		S		1,447	D	$407.44(5)	35,084	D
Common Stock	02/10/2026		S		128	D	$408.06(6)	34,956	D
Common Stock	02/10/2026		S		2,129	D	$415.91(7)	32,827	D
Common Stock	02/10/2026		S		2,533	D	$416.69(8)	30,294	D
Common Stock	02/10/2026		S		200	D	$417.61(9)	30,094	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$222.35	02/10/2026		M			7,720	(10)	02/07/2032	Common Stock	7,720	(11)	0	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $404.69 to $405.62. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

2. This transaction was executed in multiple trades at prices ranging from $405.69 to $406.68. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

3. This transaction was executed in multiple trades at prices ranging from $404.90 to $405.89. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

4. This transaction was executed in multiple trades at prices ranging from $405.92 to $406.89. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

5. This transaction was executed in multiple trades at prices ranging from $407.00 to $407.86. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

6. This transaction was executed in multiple trades at prices ranging from $408.02 to $408.07. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

7. This transaction was executed in multiple trades at prices ranging from $415.43 to $416.41. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

8. This transaction was executed in multiple trades at prices ranging from $416.44 to $417.38. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

9. This transaction was executed in multiple trades at prices ranging from $417.46 to $417.68. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

10. The option vests in three equal annual installments beginning on February 8, 2023.

11. The transaction is the exercise of a derivative security.

Remarks:

	/s/ Kevin P. Zdimal by Ronald P. Fuss, attorney-in-fact	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CSL VP & CFO Kevin P. Zdimal report?

Kevin P. Zdimal reported exercising stock options and selling common shares of Carlisle Companies (CSL). On February 10, 2026, he exercised 7,720 employee stock options and sold multiple blocks of common stock in market transactions, all reported as directly owned holdings.

How many Carlisle (CSL) shares did the CFO sell on February 10, 2026?

On February 10, 2026, the CFO sold 24,180 Carlisle common shares in several transactions. These sales were broken into multiple trades at different prices, all reported individually on the Form 4 as open-market sales coded with transaction code “S.”

At what prices did the CSL CFO’s stock sales occur on this Form 4?

The reported sales occurred at weighted average prices generally between $405.19 and $417.61 per share. Each line represents multiple trades within specified price ranges, with full trade-by-trade details available upon request from the reporting person.

How many Carlisle (CSL) shares does the CFO hold after these transactions?

Following the reported option exercise and share sales, Kevin P. Zdimal beneficially owned 30,094 Carlisle common shares. The Form 4 shows these remaining holdings as directly owned after all February 10, 2026 transactions were completed.

What options did the Carlisle CFO exercise in this Form 4 filing?

He exercised 7,720 employee stock options with an exercise price of $222.35 per share. These options were originally scheduled to vest in three equal annual installments beginning February 8, 2023, and were exercisable for Carlisle common stock.

What does transaction code “M” mean in the CSL CFO’s Form 4?

Transaction code “M” indicates the exercise or conversion of a derivative security, such as a stock option. In this filing, it reflects the exercise of employee stock options into 7,720 shares of Carlisle common stock on February 10, 2026.